TSX closed
Loading markets…

Advertisement

PARTNER SPOTLIGHT

CIBC Investor's Edge

Get 200 free trades when you open an eligible CIBC Investor's Edge account.

  • 200 free stock & ETF trades
  • Unlimited commission-free trades on 180+ select ETFs
  • Offer ends September 30, 2026
Stocks/TSX-V/QPT

Quest PharmaTech Inc (QPT : TSX-V)

Common Stock

$0.03

CAD

+0.01 (25.00%)

Last updated: 2026-09-16

Follow QPT

QPT

Quest PharmaTech Inc

Source:WealthAwesomeWealthAwesome
$0.01 (-28.57%)
30 day period
$0.02$0.03$0.04Jun 9Jul 9Sep 16

Performance

1 Day

+0.00%

1 Week

+25.00%

1 Month

+25.00%

YTD

-28.57%

Key Statistics

Market Cap

$4.23M

52W High

$0.05

52W Low

$0.02

P/E Ratio

0.83

50 Day MA

$0.02

200 Day MA

$0.03

Beta

-0.31

Dividend Yield

-

Advertisement

Technical Indicators

Price vs 50-Day SMA

Above 50 SMA

Price vs 200-Day SMA

Below 200 SMA

Recent Price History

DateOpenHighLowCloseAdj CloseVolume
9/16/2026$0.03$0.03$0.03$0.03$0.03105,200
8/27/2026$0.02$0.02$0.02$0.02$0.0210,000
8/20/2026$0.02$0.02$0.02$0.02$0.020
8/19/2026$0.02$0.02$0.02$0.02$0.0210,000
8/14/2026$0.02$0.02$0.02$0.02$0.025,500
8/12/2026$0.03$0.03$0.03$0.03$0.0340,000
8/11/2026$0.02$0.02$0.02$0.02$0.020
8/7/2026$0.02$0.02$0.02$0.02$0.0210,798
7/29/2026$0.02$0.02$0.02$0.02$0.022,000
7/24/2026$0.03$0.03$0.03$0.03$0.035,000

Wealth Awesome Price Forecast

WA Model

Statistical 90-day price range based on QPT's historical volatility

HistoricalForecast68%95%
C$0.00C$0.07C$0.15C$0.22C$0.29C$0.36TodayJan 15May 1Sep 16Oct 29Dec 12Jan 24

30-Day Vol

236.3%

Annualized

90-Day Vol

212.2%

Annualized

Trend (90d)

-50.0%

Annualized drift

90d Mean

C$0.02

Expected price

HorizonExpected68% Range (1σ)
30 trading daysC$0.02C$0.01C$0.05
60 trading daysC$0.02C$0.01C$0.07
90 trading daysC$0.02C$0.01C$0.09

Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.

About Quest PharmaTech Inc

Quest PharmaTech Inc., a pharmaceutical company, develops targeted cancer therapies in Canada. Its lead product is MAb AR9.6, a theranostic agent for cancer in preclinical development for pancreatic cancer. The company is headquartered in Edmonton, Canada.

Financials

Revenue (TTM)
$0
EBITDA
$-814,313
Profit Margin
0.00%
ROE (TTM)
20.91%
EPS (Diluted)
0.03
Book Value
0.16

Classification

Sector
Health Care
Industry
Biotechnology
Group
Pharmaceuticals, Biotechnology & Life Sciences

7 stocks to buy and hold forever

Blue-chip dividend stocks for long-term wealth building.

Get the FREE Report

Advertisement

Common Questions About QPT

Market movers

Recent TSX-V movers

Top 1-day gainers — updated from our Canadian movers feed.

All movers →
TickerNamePrice1D
ESXREssex Resources Corp.$0.40+182.14%
RCR-PCanna 8 Investment Trust$0.01+100.00%
BARKBlack Spruce Exploration Inc.$0.04+50.00%
AUGCAu Gold Corp$0.27+38.46%
TIEColoured Ties Capital Inc$1.16+36.47%
GWMGalway Metals Inc.$0.89+34.85%
FRNTFRNT Financial Inc$0.04+33.33%
SNVSonoro Energy Ltd$0.02+33.33%

QPT.V news timeline

8 articles covering QPT.V, most recent first

Latest

Why Quest PharmaTech Inc stock surged yesterday

Stocks

Advertisement